Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis.
about
Adaptive immunity in the liverGlycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical reviewThe immunogenetics of primary biliary cirrhosis: A comprehensive reviewRecent advances in the diagnosis and treatment of primary biliary cholangitis.The Immunogenetics of Autoimmune CholestasisThe role of epigenetic mechanisms and processes in autoimmune disordersOngoing activation of autoantigen-specific B cells in primary biliary cirrhosisDNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosisMolecular diagnostic testing for primary biliary cholangitis.Advances in pharmacotherapy for primary biliary cirrhosis.Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.Role of autoimmunity in primary biliary cirrhosis.The immunopathology of liver granulomas in primary biliary cirrhosis.Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisAutoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significanceGenome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisExtrahepatic autoimmune conditions associated with primary biliary cirrhosis.Women and primary biliary cirrhosis.Human autoimmune diseases: a comprehensive update.Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.Epigenetic alterations underlying autoimmune diseases.Epigenetic drug discovery: breaking through the immune barrier.Principal contribution of HLA-DQ alleles, DQB1*06:04 and DQB1*03:01, to disease resistance against primary biliary cholangitis in a Japanese population.Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis.Primary biliary cholangitis: a comprehensive overview.Possible Mediation by Methylation in Acute Inflammation Following Personal Exposure to Fine Particulate Air Pollution.Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.Investigational drugs in phase II clinical trials for primary biliary cholangitis.Primary biliary cholangitis: new treatments for an old disease.Bile Acids Activated Receptors Regulate Innate Immunity
P2860
Q26753195-BA8DA547-31EE-4CA6-8A3C-EF3D327165EEQ26782025-F14AA473-773B-4E08-8DED-BB85A6718D00Q26801377-910A84FC-6A1E-4987-A310-8C6C9E62740DQ28076353-CC2C4886-64DB-48CB-B552-23E2F943F9CCQ28085346-835D5EB1-B34B-4751-924C-82D7EC5CD37DQ28389137-2F376B36-CD22-48AB-BE59-15DBD2E8B6B1Q34415757-9CE08F47-E03F-4276-A292-2DE052FC451DQ35819281-A18E1835-E90B-46E8-9138-C19EE0E1AF90Q36086498-C082FC04-280A-4135-9E88-3E08CA5CAC06Q36116022-4F7399AF-431C-4501-9C3F-361A276901EAQ36136251-3506FD14-E919-4174-986F-DFEB82449A3FQ36529131-B1559DA0-B8C5-40C2-9F5E-F5731A3E2862Q36573783-4E5C2B3F-BC89-4D90-9175-FE6CA4398A3CQ36696219-1A50B414-4447-4B40-9CC4-3968F829868EQ37629685-2724714A-B56E-44A4-A029-A0AFA56370C9Q37683538-1059400F-7AB6-421E-BFF5-C5047A6C3946Q38210250-5130DF21-1DCB-4BF5-A83D-86AAD5419852Q38252904-0E2602B5-DB7F-443F-A206-9982DFAADA50Q38554722-0780B991-F08E-41E9-B2B1-9595989E2CACQ38565478-98B40218-E29C-43D5-ADA3-6E6A1390FBE2Q38694852-2BAA5DFA-AC05-4379-BED2-EFC614AC1C78Q38986705-BEE1E208-0631-4BFE-8DD6-72311AB2AEE1Q41328248-758739D3-9A00-473D-BD79-2AB929DC5437Q41361892-CF5388F3-1F05-4277-8A87-3213ED756522Q44913544-7DC4209A-644D-49D3-BE8D-8073FDB50152Q46078221-A0FCFFDD-D81B-4497-B399-03EC8B934DDEQ47666987-8FAE9056-B0F8-464A-AC6C-F26100E230E5Q50199708-33E556E4-3840-4B5D-918C-20728B840B1AQ53098304-49310F23-3B98-43AE-8C85-2A066398C7E6Q54390436-17789D7B-D49B-4783-8986-445D55477940Q57111959-BF12AEBB-F50F-48CE-B4FA-58C49EBB1FCA
P2860
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@ast
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@en
type
label
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@ast
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@en
prefLabel
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@ast
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@en
P2093
P2860
P50
P356
P1433
P1476
Immunoglobulin M levels invers ...... ith primary biliary cirrhosis.
@en
P2093
Gaetana Lanzi
Jieyue Liao
Peng Zhang
Qianjin Lu
P2860
P304
P356
10.1002/HEP.24630
P407
P50
P577
2011-12-06T00:00:00Z